MP41Homo sapiens (Human)Cancer cell line

🤖 AI SummaryBased on 1 publications

Quick Overview

Human uveal melanoma cell line for cancer research.

Detailed Summary

MP41 is a human uveal melanoma cell line established from patient-derived xenografts (PDXs). It exhibits a predominant epithelioid morphology and has been characterized for genetic alterations relevant to uveal melanoma. The cell line shows activation of the mTOR signaling pathway and is sensitive to the mTOR inhibitor Everolimus, demonstrating reduced cell viability and tumor growth inhibition in vivo. MP41 is used in preclinical studies to evaluate therapeutic targets and drug efficacy in uveal melanoma.

Research Applications

Cancer researchDrug screeningPreclinical testing

Key Characteristics

Epithelioid morphologymTOR pathway activationEverolimus sensitivity
Generated on 6/21/2025

Basic Information

Database IDCVCL_4D12
SpeciesHomo sapiens (Human)
Tissue SourceEye, uvea[UBERON:UBERON_0001768]

Donor Information

Age49
Age CategoryAdult
SexFemale

Disease Information

DiseaseUveal melanoma
LineageEye
SubtypeUveal Melanoma
OncoTree CodeUM

DepMap Information

Source TypeATCC
Source IDACH-002010_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleGNA11p.Gln209Leu (c.626A>T)Unspecified-PubMed=22236444

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
9,10
D13S317
11,14
D16S539
13
D21S11
30.2,31.2
D5S818
10,13
D7S820
8.3,9,9.3,10,10.1,11
TH01
6,7
TPOX
8,11
vWA
15,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target.

Roman-Roman S.

Mol. Oncol. 8:1508-1520(2014).